ISTH 2021 Congress
Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies » VWF and von Willebrand Factor Disorders - Clinical Conditions
Theme Navigation
- ISTH 2021 Congress
- Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
- VWF and von Willebrand Factor Disorders - Clinical Conditions
- Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
-
Abstract Number: PB0933
A Quantitative Evaluation of vWF Multimeric Structure in Patients with Different Types of vWD and aVWS
-
Abstract Number: PB0952
Acquired von Willebrand Disease
-
Abstract Number: PB0938
Acquired von Willebrand Disease: The Diagnosis and Management of an Underdiagnosed Coagulopathy
-
Abstract Number: LPB0031
Activity and Cleavage of von Willebrand Disease Type 2B Variants
-
Abstract Number: OC 13.3
Association of Genetic Alterations with Severity of Disease in Type III vWD Patients
-
Abstract Number: PB0943
Atypical Presentation of VWD Leading to Discovery of Novel VWF Mutation
-
Abstract Number: OC 72.1
BT200 Increases von Willebrand Factor (VWF), FVIII and Platelet Counts in Patients with von Willebrand Disease (VWD) Type IIb
-
Abstract Number: PB0924
Burden of Illness in Patients with von Willebrand Disease: A Systematic Review
-
Abstract Number: PB0927
Characteristics and Treatment of Patients with von Willebrand Disease (VWD) in General Practice Settings in the United Kingdom
-
Abstract Number: PB0923
Clinical, Economic, and Quality of Life Burden Associated with von Willebrand Disease (VWD) in Adults and Children: Systematic and Targeted Literature Reviews
-
Abstract Number: PB0935
Congenital Bleeding Disorders in Adolescent Females Evaluated for Menorrhagia and Iron Deficiency Anemia
-
Abstract Number: PB0947
Correlation of VWF:Ab to VWF:Ag Ratio and Abnormal VWF Multimer Pattern
-
Abstract Number: PB0937
Diagnosis of von Willebrand Disease-intricacies and Challenges: An Experience from a Tertiary Care Centre in Southern India
-
Abstract Number: PB0926
Don’t Let Bleeding Go Unnoticed – A Global Initiative to Increase Awareness of von Willebrand Disease
-
Abstract Number: PB0934
Efficacy of hFVIII/VWF Concentrate in Pediatric Patients with von Willebrand Disease (VWD): The French Experience
-
Abstract Number: PB0945
Finding the Balance between Bleeding Risk and Thromboembolic Risk: A Case Report
-
Abstract Number: LPB0032
Genetic Characterization of von Willebrand Disease Type 2 in Milan Cohort Patients
-
Abstract Number: PB0936
High Plasma von Willebrand Factor Level is Associated with Increased Risk of upper Gastrointestinal Bleeding in Patients with Chronic Coronary Syndromes Receiving Long-term Antiplatelet Therapy
-
Abstract Number: PB0916
Increased Cleavage of VWF by ADAMTS13 Might Reduce High-molecular-weight VWF Multimers, Leading to Acquired von Willebrand Syndrome in Patients with Essential Thrombocythemia
-
Abstract Number: PB0948
Intermittent Prophylaxis for Heavy Menstrual Bleeding in Von Willebrand Disease